These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19517894)

  • 1. Differences between original intravenous iron sucrose and iron sucrose similar preparations.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2009; 59(4):176-90. PubMed ID: 19517894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of toxicity and oxidative stress induced by intravenous iron isomaltoside 1000 in a nonclinical model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2011; 61(10):553-65. PubMed ID: 22164963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the extent of oxidative stress induced by intravenous ferumoxytol, ferric carboxymaltose, iron sucrose and iron dextran in a nonclinical model.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Arzneimittelforschung; 2011; 61(7):399-410. PubMed ID: 21899208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution and predictive hepatic gene expression of intravenous iron sucrose.
    Elford P; Bouchard J; Jaillet L; Pearson N; Rogue A; Sabadie C; Forster R
    J Pharmacol Toxicol Methods; 2013; 68(3):374-83. PubMed ID: 23624021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron and oxidative stress in renal insufficiency.
    Lim CS; Vaziri ND
    Am J Nephrol; 2004; 24(6):569-75. PubMed ID: 15550752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of early gastrointestinal tract and liver toxicity of the originator iron polymaltose complex (IPC) and an IPC similar preparation in non-anemic rats.
    Toblli JE; Cao G; Angerosa M
    Int J Clin Pharmacol Ther; 2012 Aug; 50(8):573-83. PubMed ID: 22578204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravenous iron on mononuclear cells during the haemodialysis session.
    Martin-Malo A; Merino A; Carracedo J; Alvarez-Lara MA; Ojeda R; Soriano S; Crespo R; Ramirez R; Aljama P
    Nephrol Dial Transplant; 2012 Jun; 27(6):2465-71. PubMed ID: 22207322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, safety and tolerability of intravenous ferric carboxymaltose: a dose-escalation study in volunteers with mild iron-deficiency anaemia.
    Geisser P; Banké-Bochita J
    Arzneimittelforschung; 2010; 60(6a):362-72. PubMed ID: 20648928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous iron sucrose in Chinese hemodialysis patients with renal anemia.
    Li H; Wang SX
    Blood Purif; 2008; 26(2):151-6. PubMed ID: 18212498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maintenance of elevated versus physiological iron indices in non-anaemic patients with chronic kidney disease: a randomized controlled trial.
    McMahon LP; Kent AB; Kerr PG; Healy H; Irish AB; Cooper B; Kark A; Roger SD
    Nephrol Dial Transplant; 2010 Mar; 25(3):920-6. PubMed ID: 19906658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
    Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
    Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous iron sucrose on oxidative stress in peritoneal dialysis patients.
    Saglam F; Cavdar C; Uysal S; Cavdar Z; Camsari T
    Ren Fail; 2007; 29(7):849-54. PubMed ID: 17994454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A; Bhandari S
    Trials; 2019 Apr; 20(1):194. PubMed ID: 30947751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of iron deficiency anemia and its treatment with iron polymaltose complex in pregnant rats, their fetuses and placentas: oxidative stress markers and pregnancy outcome.
    Toblli JE; Cao G; Oliveri L; Angerosa M
    Placenta; 2012 Feb; 33(2):81-7. PubMed ID: 22153683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamics and safety of ferric carboxymaltose: a multiple-dose study in patients with iron-deficiency anaemia secondary to a gastrointestinal disorder.
    Geisser P; Rumyantsev V
    Arzneimittelforschung; 2010; 60(6a):373-85. PubMed ID: 20648929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin controls oxidative stress and modulates iron, ferritin, and transferrin levels in adriamycin treated rats.
    Othman AI; El-Missiry MA; Amer MA; Arafa M
    Life Sci; 2008 Oct; 83(15-16):563-8. PubMed ID: 18793653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous versus oral iron therapy for postpartum anaemia.
    Bhandal N; Russell R
    BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.